Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction: In vitro, in vivo, and in silico integrated approaches
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis of new substituted pyridine derivatives as potent anti-liver cancer agents through apoptosis induction: In vitro, in vivo, and in silico integrated approaches
Authors
Keywords
Liver cancer, Pyridines, Apoptosis, RT-PCR, In vivo
Journal
BIOORGANIC CHEMISTRY
Volume 111, Issue -, Pages 104877
Publisher
Elsevier BV
Online
2021-03-30
DOI
10.1016/j.bioorg.2021.104877
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis
- (2020) Paramita Dasgupta et al. Frontiers in Oncology
- Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway
- (2020) Shahad W. Kattan et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Design, synthesis and antiproliferative activity of new amine, amino acid and dipeptide-coupled benzamides as potential sigma-1 receptor
- (2020) Eman Youssef et al. Journal of the Iranian Chemical Society
- Discovery of New Apoptosis-Inducing Agents for Breast Cancer Based on Ethyl 2-Amino-4,5,6,7-Tetra Hydrobenzo[b]Thiophene-3-Carboxylate: Synthesis, In Vitro, and In Vivo Activity Evaluation
- (2020) Emad M. Gad et al. MOLECULES
- Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer
- (2020) Mohamed S. Nafie et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Synthesis, characterization of some pyrazine derivatives as anti-cancer agents: In vitro and in Silico approaches
- (2020) Eman S. Tantawy et al. JOURNAL OF MOLECULAR STRUCTURE
- Antimicrobial and antiproliferative activities of novel synthesized 6‐(quinolin‐2‐ylthio) pyridine derivatives with molecular docking study as multi‐targeted JAK2/STAT3 inhibitors
- (2020) Mohamed S. Nafie et al. Chemical Biology & Drug Design
- Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells
- (2020) Mohamed S. Nafie et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New series of fused pyrazolopyridines: Synthesis, molecular modeling, antimicrobial, antiquorum-sensing and antitumor activities
- (2019) N.S. El-Gohary et al. BIOORGANIC CHEMISTRY
- Discovery of novel functionalized 1,2,4-triazoles as PARP-1 inhibitors in breast cancer: Design, synthesis and antitumor activity evaluation
- (2019) Ahmed T.A. Boraei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives
- (2019) Ahmed I. Khodair et al. CARBOHYDRATE RESEARCH
- Screening of different drug design tools to predict the mode of action of steroidal derivatives as anti-cancer agents
- (2019) Mohamed S. Nafie et al. STEROIDS
- New pyrazolopyridine analogs: Synthesis, antimicrobial, antiquorum-sensing and antitumor screening
- (2018) N.S. El-Gohary et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis, antimicrobial, antiquorum-sensing and antitumor evaluation of new series of pyrazolopyridine derivatives
- (2018) N.S. El-Gohary et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and synthesis of new phthalazine-based derivatives as potential EGFR inhibitors for the treatment of hepatocellular carcinoma
- (2018) Ahmed T.A. Boraei et al. BIOORGANIC CHEMISTRY
- Design, selective alkylation and X-ray crystal structure determination of dihydro-indolyl-1,2,4-triazole-3-thione and its 3-benzylsulfanyl analogue as potent anticancer agents
- (2017) Ahmed T.A. Boraei et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and in vitro biological evaluation of novel diaminothiophene scaffolds as antitumor and anti-influenza virus agents. Part 2
- (2017) Khurshed Bozorov et al. RSC Advances
- Targeting Pim kinases for cancer treatment: opportunities and challenges
- (2015) Bich Thuy Le et al. Future Medicinal Chemistry
- Discovery of 2-[1-(4,4-Difluorocyclohexyl)piperidin-4-yl]-6-fluoro-3-oxo-2,3-dihydro-1H-isoindole-4-carboxamide (NMS-P118): A Potent, Orally Available, and Highly Selective PARP-1 Inhibitor for Cancer Therapy
- (2015) Gianluca Papeo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers
- (2014) P. D. Garcia et al. CLINICAL CANCER RESEARCH
- Abnormal hematopoietic phenotypes in Pim kinase triple knockout mice
- (2013) Ningfei An et al. Journal of Hematology & Oncology
- Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors
- (2013) Matthew T. Burger et al. ACS Medicinal Chemistry Letters
- Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
- (2011) Arup K. Ghose et al. ACS Chemical Neuroscience
- Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery
- (2010) David C. Pryde et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pim-1 expression and monoclonal antibody targeting in human leukemia cell lines
- (2009) Jie Li et al. EXPERIMENTAL HEMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started